Akira Takeda

4PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 17, 2025
Breast cancer remodels lymphatics in sentinel lymph nodes.

Dominik Eichin, Diana Lehotina, Anni Kauko

|Jun 03, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala

|Sep 24, 2020
CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice.

Dominik Eichin, Alberto Pessia, Akira Takeda

|Mar 31, 2019
Clever-1 contributes to lymphocyte entry into the spleen via the red pulp.

Sina Tadayon, Johannes Dunkel, Akira Takeda

Pageof 1

Frequent Collaborators

3 joint publications

Maija Hollmén

2 joint publications

Reetta Virtakoivu

2 joint publications

Dominik Eichin

2 joint publications

Sirpa Jalkanen